Sangamo Therapeutics, Inc. (GBY)
Market Closed
7 Aug, 20:00
XSTU 
€
0. 11
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
640 Volume
-1.38 Eps
€ 0.11
Previous Close Want to track GBY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GBY Earnings Reports FAQ
What is the earnings per share (EPS) for GBY?
The current EPS is -1.38.
What is the company's earnings growth rate?
Sangamo Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Sangamo Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sangamo Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GBY at this time, as Sangamo Therapeutics, Inc has no recent EPS data to calculate it.
